High expression of follicle stimulating hormone receptor in testicular tissue of idiopathic azoospermic patients with severe spermatogenic defects.

BACKGROUND Follicle stimulating hormone is necessary for normal reproduction in men. The biochemical actions of follicle stimulating hormone result from binding to the follicle stimulating hormone receptor in the plasma membrane of Sertoli cells. Here, we investigated the expression of the follicle stimulating hormone receptor in different testicular histological phenotypes of patients with idiopathic azoospermia. METHODS Fifty-seven cases of idiopathic azoospermia were classified into three groups according to the results of testicular biopsy: patients with hypospermatogenesis, patients with maturation arrest, and patients with Sertoli cell-only syndrome. Thirteen azoospermic patients identified by testicular biopsy as being capable of completing spermatogenesis acted as the control group. Immunohistochemistry and real-time quantitative reverse-transcriptase polymerase chain reaction were performed in each case, and the serum hormone level was also measured in all patients. RESULTS The serum follicle stimulating hormone level in patients with Sertoli cell-only syndrome was significantly higher than in patients with hypospermatogenesis, maturation arrest, and complete spermatogenesis (P < 0.01). The serum follicle stimulating hormone level in patients with maturation arrest was significantly higher than in patients with hypospermatogenesis and complete spermatogenesis (P < 0.05). There was no difference in serum follicle stimulating hormone levels in patients with hypospermatogenesis and complete spermatogenesis. The follicle stimulating hormone receptor expression level of testicular samples with Sertoli cell-only syndrome was significantly higher than in those with hypospermatogenesis, maturation arrest, and complete spermatogenesis (P < 0.05), but no significant difference was observed among hypospermatogenesis, maturation arrest, and complete spermatogenesis testicular samples. CONCLUSIONS Different serum follicle stimulating hormone levels and follicle stimulating hormone receptor expression were found in the different testicular histology phenotypes in azoospermic patients. Differential follicle stimulating hormone receptor expression in testicular tissue of patients with idiopathic azoospermia may be associated with the degree of spermatogenesis.

[1]  Wei Li,et al.  Sertoli Cell-specific Expression of Metastasis-associated Protein 2 (MTA2) Is Required for Transcriptional Regulation of the Follicle-stimulating Hormone Receptor (FSHR) Gene during Spermatogenesis* , 2012, The Journal of Biological Chemistry.

[2]  Liying Yan,et al.  Combination of serum inhibin B and follicle-stimulating hormone levels can not improve the diagnostic accuracy on testicular sperm extraction outcomes in Chinese non-obstructive azoospermic men. , 2012, Chinese medical journal.

[3]  S. Glina,et al.  Variants in Follicle-Stimulating Hormone Receptor Gene in Infertile Brazilian Men and the Correlation to FSH Serum Levels and Sperm Count , 2012, Reproductive Sciences.

[4]  M. Safarinejad,et al.  Evaluating the role of the FSH receptor gene Thr307‐Ala and Asn680‐Ser polymorphisms in male infertility and their association with semen quality and reproductive hormones , 2011, BJU international.

[5]  Yankai Xia,et al.  FSH receptor gene polymorphisms in fertile and infertile Han-Chinese males. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[6]  M. Erdal,et al.  FSHR Single Nucleotide Polymorphism Frequencies in Proven Fathers and Infertile Men in Southeast Turkey , 2010, Journal of biomedicine & biotechnology.

[7]  M. Punab,et al.  Follicle-Stimulating Hormone Receptor Gene Haplotypes and Male Infertility in Estonian Population and Meta-Analysis , 2010, Systems biology in reproductive medicine.

[8]  C. Foresta,et al.  Follicle-stimulating hormone treatment of male infertility , 2008, Current opinion in urology.

[9]  J. Meeker,et al.  Relationships between serum hormone levels and semen quality among men from an infertility clinic. , 2006, Journal of andrology.

[10]  C. Foresta,et al.  FSH receptor gene polymorphisms in fertile and infertile Italian men. , 2006, Reproductive biomedicine online.

[11]  L. Kiesel,et al.  A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. , 2005, The Journal of clinical endocrinology and metabolism.

[12]  E. Nieschlag,et al.  Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. , 2005, Journal of andrology.

[13]  L. Kiesel,et al.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation , 2005, Pharmacogenetics and genomics.

[14]  Jing Cheng,et al.  FSH and testosterone signaling in Sertoli cells. , 2005, Reproduction.

[15]  Chung-Liang Ho,et al.  Differential expression of L-selectin ligand in the endometrium during the menstrual cycle. , 2005, Fertility and sterility.

[16]  E. Wintour,et al.  Quantitative comparison of placental expression of three aquaporin genes. , 2004, Placenta.

[17]  T. Kunej,et al.  Y chromosome microdeletions in infertile men with cryptorchidism. , 2003, Fertility and sterility.

[18]  E. Nieschlag,et al.  Manifestation of Y-chromosomal deletions in the human testis: a morphometrical and immunohistochemical evaluation. , 2002, Human reproduction.

[19]  E. Nieschlag,et al.  Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. , 2002, Human reproduction update.

[20]  K. Nagao,et al.  Microdeletions in the Y chromosome of patients with idiopathic azoospermia. , 2002, Asian journal of andrology.

[21]  I. Kang,et al.  Alternatively spliced variants of the follicle-stimulating hormone receptor gene in the testis of infertile men. , 2002, Fertility and sterility.

[22]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[23]  H. Krishnamurthy,et al.  The role of follicle-stimulating hormone in spermatogenesis: lessons from knockout animal models. , 2001, Archives of medical research.

[24]  M. Fujisawa,et al.  Y-chromosome microdeletion and phenotype in cytogenetically normal men with idiopathic azoospermia. , 2001, Fertility and sterility.

[25]  A. Roverato,et al.  Sertoli cell function in infertile patients with and without microdeletions of the azoospermia factors on the Y chromosome long arm. , 2001, The Journal of clinical endocrinology and metabolism.

[26]  H. Krishnamurthy,et al.  Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation. , 2000, The Journal of biological chemistry.

[27]  M. Fritz,et al.  Use of integrins to date the endometrium. , 2000, Fertility and sterility.

[28]  E. Nieschlag,et al.  Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  E. Nieschlag,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Dis , 2022 .

[30]  R. Anderson,et al.  Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. , 1998, Human reproduction.

[31]  K. Matsumoto,et al.  Abnormality of testicular FSH receptors in infertile men. , 1984, Acta endocrinologica.